Accelovance, a CRO focused in early phase oncology, vaccines and general medicine development, has joined the iMedNet Partner Program, established by MedNet, a global life sciences technology company specializing in clinical study management systems. Accelovance now can offer iMedNet EDC to clients as an advanced solution for the data management needs associated with clinical trial programs while providing significant cost savings compared with similar platforms.

"The adoption of the iMedNet technology further expands the available solutions within our data management offering. This is an option for sponsors with an early phase concentration and a desire to utilize a eClinical solution to enhance study efficiencies while maintaining budget discipline," said Steve Trevisan, president and CEO of Accelovance.